Jeannine Delaney has a strong background in R&D and analytical development. Jeannine currently serves as the Head of R&D at Adeptrix Corporation, where they lead various research and development activities, including assay research and optimization, protocol development, sample analysis, and data analysis. Prior to joining Adeptrix, Jeannine held the role of Sr. Director Analytical R&D at Centessa Pharmaceuticals. Jeannine also has experience as a Senior Principal Scientist at UCB and a Principal Chemist at Insulet Corporation. Throughout their career, Jeannine has demonstrated expertise in analytical method development, characterization of materials, and toxicological assessments. Jeannine has received recognition for their contributions and has managed various research programs and collaborations, including working with contract software companies and managing external testing resources.
Jeannine Delaney obtained a Ph.D. in Bio-Analytical Chemistry from Northeastern University between 1996 and 2001. Prior to that, they obtained a Bachelor of Applied Science (BASc) in Chemistry from the University of Massachusetts Lowell between 1990 and 1994. In terms of additional certifications, Jeannine completed a course on "Confronting Bias: Thriving Across Our Differences" at LinkedIn in 2021. Jeannine also has a certification in Business Process Management from Boston University, although the specific date of completion is unknown.
September, 2021 - present
Sr. Director, Biologics Value Chain Lead, Immuno-oncology Franchise at Bristol-Myers Squibb
Associate Vice President at Pyramid Consulting
Risk Manager at BNP Paribas
Supply Chain Director Team Leader at Pfizer
Manager, Logistics & Planning at Campbell Soup Company
Access the worlds's biggest network of public org charts
Learn more